<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="gsd4" content-type="chapter" from-where="body" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">gene</book-id>
    <book-title-group>
      <book-title>GeneReviews<sup>&#x000ae;</sup></book-title>
    </book-title-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Adam</surname>
          <given-names>Margaret P</given-names>
        </name>
        <role>Editor-in-Chief</role>
      </contrib>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ardinger</surname>
          <given-names>Holly H</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Pagon</surname>
          <given-names>Roberta A</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Wallace</surname>
          <given-names>Stephanie E</given-names>
        </name>
      </contrib>
      <role>Senior Editors</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Bean</surname>
          <given-names>Lora JH</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Mefford</surname>
          <given-names>Heather C</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Stephens</surname>
          <given-names>Karen</given-names>
        </name>
      </contrib>
      <role>Molecular Genetics</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Amemiya</surname>
          <given-names>Anne</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ledbetter</surname>
          <given-names>Nikki</given-names>
        </name>
      </contrib>
      <role>Genetic Counseling</role>
    </contrib-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>1993</year>
    </pub-date>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>2017</year>
    </pub-date>
    <issn>2372-0697</issn>
    <publisher>
      <publisher-name>University of Washington, Seattle</publisher-name>
      <publisher-loc>Seattle (WA)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 1993-2017, University of Washington, Seattle. GeneReviews is a registered trademark of the University of Washington, Seattle. All rights reserved.</copyright-statement>
      <copyright-year>2017</copyright-year>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://www.ncbi.nlm.nih.gov/books/NBK138602/">
        <license-p>GeneReviews&#x000ae; chapters are owned by the University of Washington. Permission is hereby granted to reproduce, distribute, and translate copies of content materials for noncommercial research purposes only, provided that (i) credit for source (<ext-link ext-link-type="uri" xlink:href="http://www.genereviews.org/">http://www.genereviews.org/</ext-link>) and copyright (&#x000a9; 1993-2017 University of Washington) are included with each copy; (ii) a link to the original material is provided whenever the material is published elsewhere on the Web; and (iii) reproducers, distributors, and/or translators comply with the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>. No further modifications are allowed. For clarity, excerpts of GeneReviews chapters for use in lab reports and clinic notes are a permitted use.</license-p>
        <license-p>For more information, see the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>.</license-p>
        <license-p>For questions regarding permissions or whether a specified use is allowed, contact: <email>admasst@uw.edu</email>.</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Genetics</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Medicine</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Diseases</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="ednotes">
      <p content-type="genetic_counseling">
<italic toggle="yes">Genetic counseling is the process of
providing individuals and families with information on the nature, inheritance,
and implications of genetic disorders to help them make informed medical and
personal decisions. The following section deals with genetic risk assessment and
the use of family history and genetic testing to clarify genetic status for
family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with
a genetics professional</italic>. &#x02014;ED.</p>
      <p content-type="resources">
<italic toggle="yes">GeneReviews staff has selected the following disease-specific and/or
umbrella support organizations and/or registries for the benefit of individuals
with this disorder and their families. GeneReviews is not responsible for the
information provided by other organizations. For information on selection
criteria, click <related-object source-id="gene" document-id="app4">here</related-object>.</italic></p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <book-part-id book-part-id-type="pmcid">gsd4</book-part-id>
      <title-group>
        <title>Glycogen Storage Disease Type IV</title>
        <alt-title alt-title-type="alt-title">Synonyms: Andersen Disease, GSD IV, Glycogen Branching Enzyme Deficiency, Glycogen Storage Disease IV, Glycogenosis IV</alt-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Magoulas</surname>
            <given-names>Pilar L</given-names>
          </name>
          <degrees>MS, CGC</degrees>
          <email>magoulas@bcm.edu</email>
          <aff>Baylor College of Medicine<break/>Texas Children&#x02019;s Hospital<break/>Houston, Texas</aff>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>El-Hattab</surname>
            <given-names>Ayman W</given-names>
          </name>
          <degrees>MD, FAAP, FACMG</degrees>
          <aff>Medical Genetics Section, Department of Pediatrics<break/>King Fahad Medical City &#x02013; Children&#x02019;s Hospital<break/>King Saud bin Abdulaziz University for Health Sciences<break/>Riyadh, Saudi Arabia</aff>
        </contrib>
      </contrib-group>
      <pub-history>
        <date iso-8601-date="2013-01-03" date-type="created">
          <day>3</day>
          <month>1</month>
          <year>2013</year>
        </date>
      </pub-history>
      <related-object link-type="parent-book-link" source-id="gene">GeneReviews<sup>&#x000ae;</sup></related-object>
      <related-object link-type="previous-part-link" source-id="gene" document-id="gsd3" document-type="chapter">Glycogen Storage Disease Type III</related-object>
      <related-object link-type="next-part-link" source-id="gene" document-id="gsd5" document-type="chapter">Glycogen Storage Disease Type V</related-object>
      <abstract id="gsd4.Summary">
        <title>Summary</title>
        <sec>
          <title>Clinical characteristics</title>
          <p>The clinical manifestations of glycogen storage disease type IV (GSD IV) discussed in this entry span a continuum of different subtypes with variable ages of onset, severity, and clinical features. Clinical findings vary extensively both within and between families.</p>
          <list list-type="bullet">
            <list-item>
              <p>The <italic toggle="yes">fatal perinatal neuromuscular subtype</italic> presents in utero with fetal akinesia deformation sequence (FADS) with decreased fetal movements, polyhydramnios, and fetal hydrops. Death usually occurs in the neonatal period.</p>
            </list-item>
            <list-item>
              <p>The <italic toggle="yes">congenital neuromuscular subtype</italic> presents in the newborn period with profound hypotonia, respiratory distress, and dilated cardiomyopathy. Death usually occurs in early infancy.</p>
            </list-item>
            <list-item>
              <p>Infants with the <italic toggle="yes">classic (progressive) hepatic subtype</italic> may appear normal at birth, but rapidly develop failure to thrive; hepatomegaly, liver dysfunction, and progressive liver cirrhosis; hypotonia; and cardiomyopathy. Without liver transplantation, death from liver failure usually occurs by age five years.</p>
            </list-item>
            <list-item>
              <p>Children with the <italic toggle="yes">non-progressive hepatic subtype</italic> tend to present with hepatomegaly, liver dysfunction, myopathy, and hypotonia; however, they are likely to survive without progression of the liver disease and may not show cardiac, skeletal muscle, or neurologic involvement.</p>
            </list-item>
            <list-item>
              <p>The <italic toggle="yes">childhood neuromuscular subtype</italic> is rare and the course is variable, ranging from onset in the second decade with a mild disease course to a more severe, progressive course resulting in death in the third decade.</p>
            </list-item>
          </list>
        </sec>
        <sec>
          <title>Diagnosis/testing</title>
          <p>The diagnosis is suspected based on the clinical presentation and the finding of abnormally branched glycogen accumulation in muscle or liver tissue. The diagnosis is confirmed by the demonstration of glycogen branching enzyme (GBE) deficiency in liver, muscle, or skin fibroblasts, and/or the identification of biallelic pathogenic variants in <italic toggle="yes">GBE1,</italic> the only gene in which pathogenic variants are known to cause GSD IV.</p>
        </sec>
        <sec>
          <title>Management</title>
          <p><italic toggle="yes">Treatment of manifestations:</italic> Management should involve a multidisciplinary team including specialists in hepatology, neurology, nutrition, medical or biochemical genetics, and child development. Liver transplantation is the only treatment option for individuals with the progressive hepatic subtype of GSD IV who develop liver failure; however, the risk for morbidity and mortality is high, in part because of the extrahepatic manifestations of GSD type IV, especially cardiomyopathy. Children with skeletal myopathy and/or hypotonia warrant developmental evaluation and physical therapy as needed. Those with cardiomyopathy warrant care by a cardiologist. Heart transplant may be an option in patients with severe cardiac involvement.</p>
          <p><italic toggle="yes">Prevention of secondary complications:</italic> Prevent nutritional deficiencies (e.g., of fat-soluble vitamins) by ensuring adequate dietary intake; prevent perioperative bleeding by assessment of a coagulation profile and use of fresh frozen plasma as needed.</p>
          <p><italic toggle="yes">Surveillance:</italic> No clinical guidelines for surveillance are available. The following evaluations are suggested (with frequency varying according to disease severity): liver function tests including liver transaminases, albumin, and coagulation profile (PT and PTT); abdominal ultrasound examination; echocardiogram; neurologic assessment; nutritional assessment. If cardiomyopathy was not observed on baseline screening echocardiogram at the time of initial diagnosis, repeat echocardiograms every three months during infancy, every six months during early childhood, and annually thereafter.</p>
          <p><italic toggle="yes">Evaluation of relatives at risk:</italic> If the <italic toggle="yes">GBE1</italic> pathogenic variants have been identified in an affected family member, test at-risk relatives to allow early diagnosis and management of disease manifestations.</p>
        </sec>
        <sec>
          <title>Genetic counseling</title>
          <p>GSD IV is inherited in an autosomal recessive manner. Each sib of an affected individual has a 25% chance of being affected, a 50% chance of being an asymptomatic carrier, and a 25% chance of being unaffected and not a carrier. Although affected sibs are expected to manifest the same subtype of GSD IV, the age of onset and presentation may differ. Carrier testing for at-risk family members and prenatal and prenatal diagnosis for pregnancies at increased risk are possible based on molecular testing if the pathogenic variants in the family have been identified. If the pathogenic variants have not been identified, glycogen branching enzyme (GBE) testing on cultured amniocytes can be performed for prenatal diagnosis.</p>
        </sec>
      </abstract>
    </book-part-meta>
    <body>
      <sec id="gsd4.Diagnosis">
        <title>Diagnosis</title>
        <p>The diagnosis of glycogen storage disease type IV (GSD IV) is suspected based on the clinical presentation and the finding of abnormally branched glycogen accumulation in muscle or liver tissue. The diagnosis is confirmed by the demonstration of glycogen branching enzyme (GBE) deficiency in liver, muscle, or skin fibroblasts [<xref ref-type="bibr" rid="gsd4.REF.brown.1983.636">Brown &#x00026; Brown 1983</xref>], and/or the identification of biallelic pathogenic variants in <italic toggle="yes">GBE1</italic>.</p>
        <sec id="gsd4.Clinical_Diagnosis">
          <title>Clinical Diagnosis</title>
          <p>GSD IV can manifest as several different subtypes, with variable ages of onset, severity, and clinical features, including the following:</p>
          <list list-type="bullet">
            <list-item>
              <p><bold>Fatal perinatal neuromuscular subtype.</bold> Decreased fetal movements, polyhydramnios, and fetal hydrops that may be detected prenatally; arthrogryposis, severe hypotonia, muscle atrophy at birth, early neonatal death</p>
            </list-item>
            <list-item>
              <p><bold>Congenital neuromuscular subtype.</bold> Profound neonatal hypotonia at birth, respiratory failure, dilated cardiomyopathy, early infantile death</p>
            </list-item>
            <list-item>
              <p><bold>Classic (progressive) hepatic subtype.</bold> Failure to thrive, hepatomegaly, liver dysfunction, progressive liver cirrhosis with portal hypertension, ascites, and esophageal varices, hypotonia, and cardiomyopathy; death typically by age five years from liver failure</p>
            </list-item>
            <list-item>
              <p><bold>Non-progressive hepatic subtype.</bold> Liver dysfunction, myopathy, and hypotonia in childhood</p>
            </list-item>
            <list-item>
              <p><bold>Childhood neuromuscular subtype.</bold> Chronic, progressive myopathy, with dilated cardiomyopathy in some</p>
            </list-item>
          </list>
          <p>Although subtypes have been recognized, the GSD IV phenotype is a continuum that ranges from mild to severe [<xref ref-type="bibr" rid="gsd4.REF.burrow.2006.878">Burrow et al 2006</xref>]. Thus, categorizing an individual or family into one specific subtype may be difficult.</p>
        </sec>
        <sec id="gsd4.Testing">
          <title>Testing</title>
          <p><bold>Liver function tests.</bold> Liver enzymes are typically elevated in the hepatic subtypes. Hypoalbuminemia and prolonged partial thromboplastin time (PTT) and prothrombin time (PT) are also observed with progressive deterioration of liver function due to the accumulation of abnormally branched glycogen. Note: These abnormalities are not specific for or diagnostic of GSD IV.</p>
          <p><bold>Abdominal ultrasound examination.</bold> The liver is typically enlarged with signs of fibrosis or cirrhosis. Note: Hepatomegaly is not specific or diagnostic for GSD IV nor does its absence rule out the diagnosis of GSD IV.</p>
          <p><bold>Glycogen branching enzyme (GBE) activity</bold> is most commonly assayed in cultured skin fibroblasts, but may also be assayed in muscle or liver tissue. All individuals with GSD IV have reduced GBE activity.</p>
          <p><bold>Histopathology</bold> of affected tissues, such as the liver, heart, or muscle, is very helpful in making an accurate diagnosis of GSD IV.</p>
          <list list-type="bullet">
            <list-item>
              <p>In general, hepatocytes are markedly enlarged and contain periodic acid-Schiff (PAS)-positive and diastase-resistant inclusions, features characteristic of the abnormally branched glycogen found in GSD IV. Widespread infiltrates of foamy histiocytes with intra-cytoplasmic deposits within the reticuloendothelial system (RES) have been reported [<xref ref-type="bibr" rid="gsd4.REF.magoulas.2012.943">Magoulas et al 2012</xref>]. Interstitial fibrosis with wide fibrous septa and distorted hepatic architecture are observed [<xref ref-type="bibr" rid="gsd4.REF.moses.2002.177">Moses &#x00026; Parvari 2002</xref>].</p>
            </list-item>
            <list-item>
              <p>Electron microscopy may demonstrate fine fibrillary aggregates of electron-dense amylopectin-like material within the cytoplasm of hepatocytes.</p>
            </list-item>
          </list>
          <sec id="gsd4.Molecular_Genetic_Testing">
            <title>Molecular Genetic Testing</title>
            <p><bold>Gene.</bold>
<italic toggle="yes">GBE1</italic> is the only gene in which pathogenic variants are known to cause glycogen storage disease type IV.</p>
            <p>
              <bold>Clinical testing</bold>
            </p>
            <table-wrap id="gsd4.T.summary_of_molecular_genetic_test" position="anchor" orientation="portrait">
              <label>Table 1. </label>
              <caption>
                <p>Summary of Molecular Genetic Testing Used in Glycogen Storage Disease Type IV</p>
              </caption>
              <table frame="hsides" rules="groups">
                <thead>
                  <tr>
                    <th id="hd_h_gsd4.T.summary_of_molecular_genetic_test_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Gene&#x000a0;<sup>1</sup></th>
                    <th id="hd_h_gsd4.T.summary_of_molecular_genetic_test_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Test Method</th>
                    <th id="hd_h_gsd4.T.summary_of_molecular_genetic_test_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Allelic Variants Detected&#x000a0;<sup>2</sup></th>
                    <th id="hd_h_gsd4.T.summary_of_molecular_genetic_test_1_1_1_4" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Variant Detection Frequency by Test Method&#x000a0;<sup>3,&#x000a0;4</sup></th>
                  </tr>
                </thead>
                <tbody>
                  <tr>
                    <td headers="hd_h_gsd4.T.summary_of_molecular_genetic_test_1_1_1_1" rowspan="2" valign="middle" align="left" scope="row" colspan="1">
                      <italic toggle="yes">GBE1</italic>
                    </td>
                    <td headers="hd_h_gsd4.T.summary_of_molecular_genetic_test_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Sequence analysis&#x000a0;<sup>3</sup></td>
                    <td headers="hd_h_gsd4.T.summary_of_molecular_genetic_test_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Sequence variants</td>
                    <td headers="hd_h_gsd4.T.summary_of_molecular_genetic_test_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">34/37&#x000a0;<sup>4</sup></td>
                  </tr>
                  <tr>
                    <td headers="hd_h_gsd4.T.summary_of_molecular_genetic_test_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">Deletion/duplication analysis&#x000a0;<sup>5</sup></td>
                    <td headers="hd_h_gsd4.T.summary_of_molecular_genetic_test_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Exon or whole-gene deletions</td>
                    <td headers="hd_h_gsd4.T.summary_of_molecular_genetic_test_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">7/37&#x000a0;<sup>6</sup></td>
                  </tr>
                </tbody>
              </table>
              <table-wrap-foot>
                <fn id="gsd4.TF.1.1">
                  <label>1. </label>
                  <p>See <related-object source-id="gene" document-id="gsd4" object-id="gsd4.molgen.TA">Table A. Genes and Databases</related-object> for chromosome locus and protein.</p>
                </fn>
                <fn id="gsd4.TF.1.2">
                  <label>2. </label>
                  <p>See <xref ref-type="sec" rid="gsd4.Molecular_Genetics">Molecular Genetics</xref> for information on allelic variants.</p>
                </fn>
                <fn id="gsd4.TF.1.3">
                  <label>3. </label>
                  <p>The ability of the test method used to detect a variant that is present in the indicated gene</p>
                </fn>
                <fn id="gsd4.TF.1.4">
                  <label>4. </label>
                  <p><xref ref-type="bibr" rid="gsd4.REF.bao.1996.941">Bao et al [1996]</xref>, <xref ref-type="bibr" rid="gsd4.REF.bruno.1999.403">Bruno et al [1999]</xref>, <xref ref-type="bibr" rid="gsd4.REF.nambu.2003.392">Nambu et al [2003]</xref>, <xref ref-type="bibr" rid="gsd4.REF.bruno.2004.1053">Bruno et al [2004]</xref>, <xref ref-type="bibr" rid="gsd4.REF.janecke.2004.705">Janecke et al [2004]</xref>, <xref ref-type="bibr" rid="gsd4.REF.tay.2004.253">Tay et al [2004]</xref>, <xref ref-type="bibr" rid="gsd4.REF.lhermin_coulomb.2005.118">L'Hermin&#x000e9;-Coulomb et al [2005]</xref>, <xref ref-type="bibr" rid="gsd4.REF.akman.2006.951">Akman et al [2006]</xref>, <xref ref-type="bibr" rid="gsd4.REF.burrow.2006.878">Burrow et al [2006]</xref>, <xref ref-type="bibr" rid="gsd4.REF.shin.2006.115">Shin [2006]</xref>, <xref ref-type="bibr" rid="gsd4.REF.assereto.2007.445">Assereto et al [2007]</xref>, <xref ref-type="bibr" rid="gsd4.REF.nolte.2008.491">Nolte et al [2008]</xref>, <xref ref-type="bibr" rid="gsd4.REF.raju.2008.349">Raju et al [2008]</xref>, <xref ref-type="bibr" rid="gsd4.REF.lamperti.2009.s161">Lamperti et al [2009]</xref>, <xref ref-type="bibr" rid="gsd4.REF.li.2010.s83">Li et al [2010]</xref>, <xref ref-type="bibr" rid="gsd4.REF.li.2012.204">Li et al [2012]</xref>, <xref ref-type="bibr" rid="gsd4.REF.magoulas.2012.943">Magoulas et al [2012]</xref></p>
                </fn>
                <fn id="gsd4.TF.1.5">
                  <label>5. </label>
                  <p>Examples of pathogenic variants detected by sequence analysis may include small intragenic deletions/insertions and missense, nonsense, and splice site variants; typically, exon or whole-gene deletions/duplications are not detected. For issues to consider in interpretation of sequence analysis results, click <related-object link-type="booklink" source-id="gene" document-id="app2" document-type="appendix">here</related-object>.</p>
                </fn>
                <fn id="gsd4.TF.1.6">
                  <label>6. </label>
                  <p>Of 37 affected individuals, 28 had biallelic pathogenic variants and six had one identifiable pathogenic variant, implying that the second causative variant was not identified.</p>
                </fn>
                <fn id="gsd4.TF.1.7">
                  <label>7. </label>
                  <p>Testing that identifies deletions/duplications not readily detectable by sequence analysis of the coding and flanking intronic regions of genomic DNA; included in the variety of methods that may be used are: quantitative PCR, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and chromosomal microarray (CMA) that includes this gene/chromosome segment.</p>
                </fn>
                <fn id="gsd4.TF.1.8">
                  <label>8. </label>
                  <p>Of 37 affected individuals, three were homozygous for exon or multiexon deletions and four were compound heterozygous for one exon or multiexon deletion and one sequence variant detectable by sequence analysis [<xref ref-type="bibr" rid="gsd4.REF.li.2012.204">Li et al 2012</xref>, <xref ref-type="bibr" rid="gsd4.REF.magoulas.2012.943">Magoulas et al 2012</xref>].</p>
                </fn>
              </table-wrap-foot>
            </table-wrap>
          </sec>
        </sec>
        <sec id="gsd4.Testing_Strategy">
          <title>Testing Strategy</title>
          <p>
            <bold>To confirm/establish the diagnosis in a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>If a liver biopsy, obtained as a part of the workup for hepatomegaly and abnormal liver function studies, shows PAS-positive and partially diastase-resistant deposits (i.e., abnormally branched glycogen) within the hepatocyte cytoplasm, additional recommended studies are typically glycogen branching enzyme (GBE) assay and/or <italic toggle="yes">GBE1</italic> molecular genetic testing.</p>
            </list-item>
            <list-item>
              <p>If GSD IV is suspected based on clinical findings and liver biopsy cannot be performed, additional recommended studies are typically GBE assay on fibroblast or muscle tissue, and/or <italic toggle="yes">GBE1</italic> molecular genetic testing.</p>
            </list-item>
          </list>
          <p><bold>Carrier testing for at-risk relatives</bold> requires prior identification of the pathogenic variants in the family, the preferred method of carrier detection<italic toggle="yes">.</italic></p>
          <p>Note: (1) Analysis of GBE activity alone is not sufficient to determine carrier status since enzyme activity in carriers may be within the normal range. (2) Carriers are heterozygotes for this autosomal recessive disorder and are not at risk of developing the disorder.</p>
          <p><bold>Prenatal diagnosis and preimplantation genetic diagnosis (PGD)</bold> for at-risk pregnancies require prior identification of the pathogenic variants in the family. If the pathogenic variants have not been identified, GBE activity can be measured in cultured amniocytes.</p>
        </sec>
      </sec>
      <sec id="gsd4.Clinical_Characteristics">
        <title>Clinical Characteristics</title>
        <sec id="gsd4.Clinical_Description">
          <title>Clinical Description</title>
          <p>The clinical manifestations of glycogen storage disease type IV (GSD IV) span a continuum from mild to severe [<xref ref-type="bibr" rid="gsd4.REF.burrow.2006.878">Burrow et al 2006</xref>]. Within this continuum several different subtypes with variable age of onset, severity, and clinical features have been recognized. Although prognosis tends to depend on the subtype of GSD IV, clinical findings vary extensively both within and between families.</p>
          <p>The <bold>fatal perinatal neuromuscular subtype</bold>, the most severe subtype, presents in utero with fetal akinesia deformation sequence (FADS) with decreased fetal movements, polyhydramnios, and fetal hydrops. Newborns may have arthrogryposis, severe hypotonia, and muscular atrophy, often resembling infants with the severe forms of <related-object link-type="booklink" source-id="gene" document-id="sma" document-type="chapter">spinal muscular atrophy</related-object> [<xref ref-type="bibr" rid="gsd4.REF.janecke.2004.705">Janecke et al 2004</xref>, <xref ref-type="bibr" rid="gsd4.REF.tay.2004.253">Tay et al 2004</xref>]. Death usually occurs in the neonatal period frequently due to cardiopulmonary compromise.</p>
          <p>The <bold>congenital neuromuscular subtype</bold> presents in the newborn period with profound hypotonia, respiratory distress, dilated cardiomyopathy, and death in early infancy typically due to cardiopulmonary compromise [<xref ref-type="bibr" rid="gsd4.REF.moses.2002.177">Moses &#x00026; Parvari 2002</xref>]. <xref ref-type="bibr" rid="gsd4.REF.li.2012.204">Li et al [2012]</xref> recently reported two unrelated infants with this subtype of GSD IV who were also small for gestational age. Both died between ages two and three months.</p>
          <p>The <bold>hepatic subtype</bold>, the most common presentation of GSD IV, can be classified as progressive (classic) or non-progressive.</p>
          <p>In the progressive hepatic subtype children may appear normal at birth, but then rapidly deteriorate in the first few months of life with failure to thrive, hepatomegaly, and elevated liver enzymes. This stage is typically followed by progressive liver dysfunction and cirrhosis with hypoalbuminemia, prolonged partial thromboplastin time (PTT) and prothrombin time (PT), portal hypertension, ascites, and esophageal varices. Muscle tone, often normal at the time of diagnosis, progresses to generalized hypotonia within the first one to two years of life [<xref ref-type="bibr" rid="gsd4.REF.magoulas.2012.943">Magoulas et al 2012</xref>]. Without liver transplantation, death from liver failure usually occurs by age five years [<xref ref-type="bibr" rid="gsd4.REF.chen.2001">Chen 2001</xref>, <xref ref-type="bibr" rid="gsd4.REF.moses.2002.177">Moses &#x00026; Parvari 2002</xref>]. Dilated cardiomyopathy and progressive cardiac failure, reported to occur following orthotopic liver transplantation, have resulted in death [<xref ref-type="bibr" rid="gsd4.REF.sokal.1992.200">Sokal et al 1992</xref>, <xref ref-type="bibr" rid="gsd4.REF.rosenthal.1995.373">Rosenthal et al 1995</xref>].</p>
          <p>In the less common non-progressive hepatic subtype, presentation can be in childhood with hepatomegaly, liver dysfunction, myopathy, and hypotonia. These individuals tend to survive without evidence of progression of the liver disease [<xref ref-type="bibr" rid="gsd4.REF.moses.2002.177">Moses &#x00026; Parvari 2002</xref>]. They also may not show cardiac, skeletal muscle, or neurologic involvement. Liver enzymes are usually abnormal in childhood at the time of presentation, but subsequently may return to (and remain) normal [<xref ref-type="bibr" rid="gsd4.REF.mcconkierosell.1996.51">McConkie-Rosell et al 1996</xref>].</p>
          <p>The <bold>childhood neuromuscular subtype</bold> of GSD IV is rare [<xref ref-type="bibr" rid="gsd4.REF.reusche.1992.36">Reusche et al 1992</xref>, <xref ref-type="bibr" rid="gsd4.REF.schr_der.1993.419">Schr&#x000f6;der et al 1993</xref>]. Individuals typically present in the second decade and may have mild to severe myopathy and dilated cardiomyopathy. The natural history is variable: some individuals have a mild disease course throughout life while others have a more severe, progressive course resulting in death in the third decade.</p>
        </sec>
        <sec id="gsd4.GenotypePhenotype_Correlations">
          <title>Genotype-Phenotype Correlations</title>
          <p>Genotype-phenotype correlations between phenotypes associated with biallelic <italic toggle="yes">GBE1</italic> pathogenic variants (various subtypes of GSD IV and APBD; see <xref ref-type="sec" rid="gsd4.Genetically_Related_Allelic_Disorde">Genetically Related Disorders</xref>) remain unclear, but are emerging [<xref ref-type="bibr" rid="gsd4.REF.bao.1996.941">Bao et al 1996</xref>, <xref ref-type="bibr" rid="gsd4.REF.ziemssen.2000.536">Ziemssen et al 2000</xref>, <xref ref-type="bibr" rid="gsd4.REF.nambu.2003.392">Nambu et al 2003</xref>, <xref ref-type="bibr" rid="gsd4.REF.bruno.2004.1053">Bruno et al 2004</xref>, <xref ref-type="bibr" rid="gsd4.REF.janecke.2004.705">Janecke et al 2004</xref>, <xref ref-type="bibr" rid="gsd4.REF.assereto.2007.445">Assereto et al 2007</xref>, <xref ref-type="bibr" rid="gsd4.REF.magoulas.2012.943">Magoulas et al 2012</xref>].</p>
          <p>APBD is typically the result of homozygous or compound heterozygous pathogenc missense variants (<xref ref-type="table" rid="gsd4.T.selected_gbe1_pathogenic_variants">Table 2</xref>).</p>
          <p>In GSD IV, generally:</p>
          <list list-type="bullet">
            <list-item>
              <p>Individuals with the perinatal and congenital subtypes tend to have two null variants, including nonsense, frameshift, and splice site variants leading to premature truncation of the protein likely resulting in complete absence of glycogen branching enzyme (GBE) activity;</p>
            </list-item>
            <list-item>
              <p>Individuals with the classic hepatic subtype tend to be compound heterozygotes for a null and a missense variant.</p>
            </list-item>
          </list>
          <p>Despite these generalizations, considerable overlap exists both between and within the subtypes of GSD IV [<xref ref-type="bibr" rid="gsd4.REF.li.2010.s83">Li et al 2010</xref>].</p>
        </sec>
        <sec id="gsd4.Penetrance">
          <title>Penetrance</title>
          <p>Penetrance for GSD IV is complete in those with biallelic pathogenic variants but shows extensive clinical variability between families and may show age-related progression of symptoms over time.</p>
        </sec>
        <sec id="gsd4.Prevalence">
          <title>Prevalence</title>
          <p>Glycogen storage disease type IV is rare, accounting for approximately 3% of the glycogen storage diseases [<xref ref-type="bibr" rid="gsd4.REF.chen.2001">Chen 2001</xref>] for an overall incidence of approximately 1:600,000-1:800,000.</p>
          <p>To date, 37 individuals with molecularly confirmed GSD IV have been reported [<xref ref-type="bibr" rid="gsd4.REF.bao.1996.941">Bao et al 1996</xref>, <xref ref-type="bibr" rid="gsd4.REF.bruno.1999.403">Bruno et al 1999</xref>, <xref ref-type="bibr" rid="gsd4.REF.nambu.2003.392">Nambu et al 2003</xref>, <xref ref-type="bibr" rid="gsd4.REF.bruno.2004.1053">Bruno et al 2004</xref>, <xref ref-type="bibr" rid="gsd4.REF.janecke.2004.705">Janecke et al 2004</xref>, <xref ref-type="bibr" rid="gsd4.REF.tay.2004.253">Tay et al 2004</xref>, <xref ref-type="bibr" rid="gsd4.REF.lhermin_coulomb.2005.118">L'Hermin&#x000e9;-Coulomb et al 2005</xref>, <xref ref-type="bibr" rid="gsd4.REF.akman.2006.951">Akman et al 2006</xref>, <xref ref-type="bibr" rid="gsd4.REF.burrow.2006.878">Burrow et al 2006</xref>, <xref ref-type="bibr" rid="gsd4.REF.shin.2006.115">Shin 2006</xref>, <xref ref-type="bibr" rid="gsd4.REF.assereto.2007.445">Assereto et al 2007</xref>, <xref ref-type="bibr" rid="gsd4.REF.nolte.2008.491">Nolte et al 2008</xref>, <xref ref-type="bibr" rid="gsd4.REF.raju.2008.349">Raju et al 2008</xref>, <xref ref-type="bibr" rid="gsd4.REF.lamperti.2009.s161">Lamperti et al 2009</xref>, <xref ref-type="bibr" rid="gsd4.REF.li.2010.s83">Li et al 2010</xref>, <xref ref-type="bibr" rid="gsd4.REF.li.2012.204">Li et al 2012</xref>, <xref ref-type="bibr" rid="gsd4.REF.magoulas.2012.943">Magoulas et al 2012</xref>].</p>
        </sec>
      </sec>
      <sec id="gsd4.Genetically_Related_Allelic_Disorde">
        <title>Genetically Related (Allelic) Disorders</title>
        <p>Adult-onset polyglucosan body disease (APBD) is the only other phenotype known to be associated with mutation of <italic toggle="yes">GBE1</italic> (see <related-object link-type="booklink" source-id="gene" document-id="apbd" document-type="chapter">Adult Polyglucosan Body Disease</related-object>). APBD is characterized by adult-onset progressive neurogenic bladder, gait difficulties (i.e., spasticity and weakness) from mixed upper and lower motor neuron involvement, sensory loss predominantly in the distal lower extremities, and mild cognitive difficulties (often executive dysfunction). In APBD GBE activity is reduced or normal. Affected individuals are either homozygous or compound heterozygous for a pathogenc missense variant in <italic toggle="yes">GBE1</italic> including <xref ref-type="table" rid="gsd4.T.selected_gbe1_pathogenic_variants">p.Tyr329Ser</xref>, <xref ref-type="table" rid="gsd4.T.selected_gbe1_pathogenic_variants">p.Arg515His</xref>, and <xref ref-type="table" rid="gsd4.T.selected_gbe1_pathogenic_variants">p.Arg524Gln</xref> [<xref ref-type="bibr" rid="gsd4.REF.lossos.1998.867">Lossos et al 1998</xref>, <xref ref-type="bibr" rid="gsd4.REF.ziemssen.2000.536">Ziemssen et al 2000</xref>, <xref ref-type="bibr" rid="gsd4.REF.klein.2004.323">Klein et al 2004</xref>]. Inheritance is autosomal recessive.</p>
      </sec>
      <sec id="gsd4.Differential_Diagnosis">
        <title>Differential Diagnosis</title>
        <p>Differential diagnoses for the <bold>perinatal and congenital neuromuscular subtypes</bold> of GSD IV include <related-object link-type="booklink" source-id="gene" document-id="sma" document-type="chapter">spinal muscular atrophy</related-object>, <related-object link-type="booklink" source-id="gene" document-id="gsd2" document-type="chapter">Pompe disease</related-object>, <related-object link-type="booklink" source-id="gene" document-id="pbd" document-type="chapter">Zellweger syndrome</related-object>, and <related-object link-type="booklink" source-id="gene" document-id="cdg" document-type="chapter">congenital disorders of glycosylation</related-object>.</p>
        <p>Differential diagnoses for the <bold>classic hepatic subtype</bold> of GSD IV include other glycogen storage disorders (e.g., <related-object link-type="booklink" source-id="gene" document-id="gsd3" document-type="chapter">GSD III</related-object>) and mitochondrial DNA depletion syndromes (e.g., <related-object link-type="booklink" source-id="gene" document-id="mpv17-mtdep" document-type="chapter"><italic toggle="yes">MPV17</italic>-related hepatocerebral mitochondrial DNA depletion syndrome</related-object>, <related-object link-type="booklink" source-id="gene" document-id="dguok-mtddepl" document-type="chapter"><italic toggle="yes">DGUOK</italic>-related mitochondrial DNA depletion syndrome, hepatocerebral form</related-object>).</p>
        <p>Differential diagnoses for the <bold>childhood neuromuscular subtype</bold> of GSD IV include muscular dystrophies (e.g., <related-object link-type="booklink" source-id="gene" document-id="dbmd" document-type="chapter">Duchenne muscular dystrophy</related-object>, <related-object link-type="booklink" source-id="gene" document-id="lgmd-overview" document-type="chapter">limb-girdle muscular dystrophy</related-object>) and <related-object link-type="booklink" source-id="gene" document-id="mt-overview" document-type="chapter">mitochondrial myopathies</related-object>.</p>
      </sec>
      <sec id="gsd4.Management">
        <title>Management</title>
        <sec id="gsd4.Evaluations_Following_Initial_Diagn">
          <title>Evaluations Following Initial Diagnosis</title>
          <p>To establish the extent of disease and needs of an individual diagnosed with glycogen storage disease type IV (GSD IV), the following evaluations are recommended:</p>
          <list list-type="bullet">
            <list-item>
              <p>Liver function studies including albumin, transaminases, and coagulation profile</p>
            </list-item>
            <list-item>
              <p>Abdominal ultrasound examination to assess liver size and texture</p>
            </list-item>
            <list-item>
              <p>Referral to a cardiologist for baseline echocardiogram and electrocardiogram (ECG) to assess for cardiomyopathy</p>
            </list-item>
            <list-item>
              <p>Neurodevelopmental evaluation</p>
            </list-item>
            <list-item>
              <p>Neurologic consultation and comprehensive neurologic examination with a baseline assessment of skeletal muscle involvement that can be used to monitor disease progression</p>
            </list-item>
            <list-item>
              <p>Medical or biochemical genetics consultation</p>
            </list-item>
          </list>
        </sec>
        <sec id="gsd4.Treatment_of_Manifestations">
          <title>Treatment of Manifestations</title>
          <p>Management should involve a multidisciplinary team including specialists in hepatology, neurology, nutrition, medical or biochemical genetics, and child development.</p>
          <p><bold>Hepatic manifestations.</bold> Liver transplantation is the only treatment option for individuals with the progressive hepatic subtype of GSD IV who develop liver failure. Of the 18 individuals with GSD IV who have received a liver transplant to date, two required a second liver transplant and six died: four from sepsis, one from hepatic artery thrombosis, and one from cardiomyopathy. The prognosis in persons with GSD IV who undergo liver transplantation is poor because of the significant risk for morbidity and mortality, which is in part attributed to the extrahepatic manifestations of GSD type IV, especially cardiomyopathy [<xref ref-type="bibr" rid="gsd4.REF.davis.2008.137">Davis &#x00026; Weinstein 2008</xref>, <xref ref-type="bibr" rid="gsd4.REF.magoulas.2012.943">Magoulas et al 2012</xref>].</p>
          <p>Selecting appropriate candidates for liver transplantation can be complex. Histologic, molecular, or clinical predictors of disease progression are likely to be useful in stratifying patients prior to liver transplantation [<xref ref-type="bibr" rid="gsd4.REF.davis.2008.137">Davis &#x00026; Weinstein 2008</xref>]. Factors such as glycogen branching enzyme (GBE) activity may not be the best predictor of outcome since the level of GBE activity in different tissues can vary by disease subtype and severity.</p>
          <p><bold>Neurologic manifestations.</bold> Children with skeletal myopathy and/or hypotonia who experience motor developmental delay warrant developmental evaluation and physical therapy as needed.</p>
          <p><bold>Cardiac manifestations</bold>. For those with cardiomyopathy, care by a cardiologist is warranted. Individuals with severe cardiomyopathy secondary to glycogenosis may be candidates for cardiac transplantation [<xref ref-type="bibr" rid="gsd4.REF.ewert.1999.850">Ewert et al 1999</xref>]; however, consideration of potential contraindications to cardiac transplantation, including myopathy, liver failure, and cachexia, is essential before pursuing this treatment option.</p>
        </sec>
        <sec id="gsd4.Prevention_of_Secondary_Complicatio">
          <title>Prevention of Secondary Complications</title>
          <p>Nutritional deficiencies (e.g., of fat-soluble vitamins) can be prevented by ensuring adequate dietary intake based on frequent assessments by and recommendations of a dietitian experienced in managing children with liver disease.</p>
          <p>Bleeding due to coagulopathy can occur especially with surgical procedures; therefore, it is recommended that a coagulation profile be assessed before surgical procedures and fresh frozen plasma be given preoperatively as needed.</p>
        </sec>
        <sec id="gsd4.Surveillance">
          <title>Surveillance</title>
          <p>No clinical guidelines for surveillance are available.</p>
          <p>The following evaluations are suggested with frequency varying according to the severity of the condition:</p>
          <list list-type="bullet">
            <list-item>
              <p>Liver function tests including liver transaminases, albumin, and coagulation profile (PT and PTT)</p>
            </list-item>
            <list-item>
              <p>Abdominal ultrasound examination</p>
            </list-item>
            <list-item>
              <p>Echocardiogram</p>
            </list-item>
            <list-item>
              <p>Neurologic assessment</p>
            </list-item>
            <list-item>
              <p>Nutritional assessment</p>
            </list-item>
          </list>
          <p>Note: If cardiomyopathy was not observed on the baseline screening echocardiogram at the time of initial diagnosis, repeat echocardiograms are recommended every three months during infancy, every six months during early childhood, and annually thereafter.</p>
        </sec>
        <sec id="gsd4.Evaluation_of_Relatives_at_Risk">
          <title>Evaluation of Relatives at Risk</title>
          <p>If the <italic toggle="yes">GBE1</italic> pathogenic variants have been identified in an affected family member, at-risk relatives can be tested so that those with the pathogenic variants can be evaluated for involvement of the liver, skeletal muscle, and heart to allow early diagnosis and management of disease manifestations.</p>
          <p>See <xref ref-type="sec" rid="gsd4.Related_Genetic_Counseling_Issues">Genetic Counseling</xref> for issues related to testing of at-risk relatives for genetic counseling purposes.</p>
        </sec>
        <sec id="gsd4.Therapies_Under_Investigation">
          <title>Therapies Under Investigation</title>
          <p>Search <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.clinicaltrials.gov">ClinicalTrials.gov</ext-link> for access to information on clinical studies for a wide range of diseases and conditions. Note: There may not be clinical trials for this disorder.</p>
        </sec>
      </sec>
      <sec id="gsd4.Genetic_Counseling">
        <title>Genetic Counseling</title>
        <sec id="gsd4.Mode_of_Inheritance">
          <title>Mode of Inheritance</title>
          <p>Glycogen storage disease type IV (GSD IV) is inherited in an autosomal recessive manner.</p>
        </sec>
        <sec id="gsd4.Risk_to_Family_Members">
          <title>Risk to Family Members</title>
          <p>
            <bold>Parents of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The parents of an affected child are obligate heterozygotes (i.e., carriers of one mutant allele).</p>
            </list-item>
            <list-item>
              <p>Heterozygotes (carriers) are asymptomatic.</p>
            </list-item>
          </list>
          <p>
            <bold>Sibs of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>At conception, each sib of an affected individual has a 25% chance of being affected, a 50% chance of being an asymptomatic carrier, and a 25% chance of being unaffected and not a carrier. Although affected sibs are expected to manifest the same subtype of GSD IV, the age of onset and presentation may differ.</p>
            </list-item>
            <list-item>
              <p>Once an at-risk sib is known to be unaffected, the risk of his/her being a carrier is 2/3.</p>
            </list-item>
            <list-item>
              <p>Heterozygotes (carriers) are asymptomatic.</p>
            </list-item>
          </list>
          <p><bold>Offspring of a proband.</bold> The offspring of an individual with glycogen storage disease type IV are obligate heterozygotes (carriers) for a pathogenic variant in <italic toggle="yes">GBE1</italic>.</p>
          <p><bold>Other family members.</bold> Each sib of the proband&#x02019;s parents is at a 50% risk of being a carrier.</p>
        </sec>
        <sec id="gsd4.Carrier_Detection">
          <title>Carrier Detection</title>
          <p><bold>Molecular genetic testing.</bold> Molecular genetic testing is the preferred method for determining an individual&#x02019;s carrier status. Carrier testing for at-risk family members is possible if the pathogenic variants in the family have been identified.</p>
          <p><bold>Biochemical genetic testing.</bold> Analysis of glycogen branching enzyme (GBE) activity alone is not sufficient to determine carrier status since enzyme activity in carriers may be within the normal range.</p>
        </sec>
        <sec id="gsd4.Related_Genetic_Counseling_Issues">
          <title>Related Genetic Counseling Issues</title>
          <p>See Management, <xref ref-type="sec" rid="gsd4.Evaluation_of_Relatives_at_Risk">Evaluation of Relatives at Risk</xref> for information on evaluating at-risk relatives for the purpose of early diagnosis and treatment.</p>
          <p>
            <bold>Family planning</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The optimal time for determination of genetic risk, clarification of carrier status, and discussion of the availability of prenatal testing is before pregnancy.</p>
            </list-item>
            <list-item>
              <p>It is appropriate to offer genetic counseling (including discussion of potential risks to offspring and reproductive options) to young adults who are affected, are carriers, or are at risk of being carriers.</p>
            </list-item>
          </list>
          <p><bold>DNA banking</bold> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of affected individuals.</p>
        </sec>
        <sec id="gsd4.Prenatal_Testing">
          <title>Prenatal Testing</title>
          <p><bold>Molecular genetic testing.</bold> If the pathogenic variants have been identified in the family, prenatal testing for pregnancies at increased risk may be available from a clinical laboratory offering either testing of the gene of interest or custom testing.</p>
          <p><bold>Biochemical genetic testing.</bold> Prenatal testing is possible by analysis of glycogen branching enzyme (GBE) activity in amniocytes or cultured chorionic villi obtained by amniocentesis usually performed at approximately 15 to 18 weeks&#x02019; gestation or chorionic villus sampling (CVS) at approximately ten to 12 weeks&#x02019; gestation.</p>
          <p>Note: Gestational age is expressed as menstrual weeks calculated either from the first day of the last normal menstrual period or by ultrasound measurements.</p>
          <p><bold>Preimplantation genetic diagnosis (PGD)</bold> may be an option for some families in which the pathogenic variants have been identified.</p>
        </sec>
      </sec>
      <sec id="gsd4.Resources">
        <title>Resources</title>
      </sec>
      <sec id="gsd4.Molecular_Genetics">
        <title>Molecular Genetics</title>
        <p><bold>Gene structure.</bold>
<italic toggle="yes">GBE1</italic> comprises 16 exons. For a detailed summary of gene and protein information, see <related-object source-id="gene" document-id="gsd4" object-id="gsd4.molgen.TA">Table A</related-object>, <bold>Gene</bold>.</p>
        <p><bold>Pathogenic allelic variants.</bold> To date, 40 <italic toggle="yes">GBE1</italic> pathogenic variants have been identified in individuals with GSD IV or adult-onset polyglucosan body disease (APBD). See <xref ref-type="sec" rid="gsd4.Genetically_Related_Allelic_Disorde">Genetically Related Disorders</xref>, <xref ref-type="table" rid="gsd4.T.selected_gbe1_pathogenic_variants">Table 2</xref>, and <inline-supplementary-material xmlns:xlink="http://www.w3.org/1999/xlink" xlink:title="media" xlink:href="gsd4-Table3.pdf" content-type="local-data">Table 3</inline-supplementary-material> (pdf).</p>
        <p>Of the 40 <italic toggle="yes">GBE1</italic> pathogenic variants, 16 are missense, six nonsense, five splice-site, seven frameshift, and six exon or multiexon deletions [<xref ref-type="bibr" rid="gsd4.REF.li.2012.204">Li et al 2012</xref>, <xref ref-type="bibr" rid="gsd4.REF.magoulas.2012.943">Magoulas et al 2012</xref>].</p>
        <p>Seven of the 40 pathogenic variants are located in exon 12, previously reported as a potential mutation hotspot [<xref ref-type="bibr" rid="gsd4.REF.moses.2002.177">Moses &#x00026; Parvari 2002</xref>].</p>
        <p>Of the 40 pathogenic variants identified, 29 are within the catalytic domain of the enzyme. Twelve of the 16 missense variants have occurred in the enzyme catalytic domain, indicating that such variants disturb the enzymatic activity of the protein [<xref ref-type="bibr" rid="gsd4.REF.magoulas.2012.943">Magoulas et al 2012</xref>].</p>
        <table-wrap id="gsd4.T.selected_gbe1_pathogenic_variants" position="anchor" orientation="portrait">
          <label>Table 2.</label>
          <caption>
            <p>Selected <italic toggle="yes">GBE1</italic> Pathogenic Variants</p>
          </caption>
          <table frame="hsides" rules="groups">
            <thead>
              <tr>
                <th id="hd_h_gsd4.T.selected_gbe1_pathogenic_variants_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">DNA Nucleotide Change</th>
                <th id="hd_h_gsd4.T.selected_gbe1_pathogenic_variants_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Protein Amino Acid Change</th>
                <th id="hd_h_gsd4.T.selected_gbe1_pathogenic_variants_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Clinical Phenotype</th>
                <th id="hd_h_gsd4.T.selected_gbe1_pathogenic_variants_1_1_1_4" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Reference Sequences</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td headers="hd_h_gsd4.T.selected_gbe1_pathogenic_variants_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.986A&#x0003e;C</td>
                <td headers="hd_h_gsd4.T.selected_gbe1_pathogenic_variants_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Tyr329Ser</td>
                <td headers="hd_h_gsd4.T.selected_gbe1_pathogenic_variants_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Non-progressive hepatic, APBD</td>
                <td headers="hd_h_gsd4.T.selected_gbe1_pathogenic_variants_1_1_1_4" rowspan="3" valign="middle" align="left" colspan="1">
                  <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/NM_000158.3">NM_000158.3</ext-link>
                  <break/>
                  <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/protein/NP_000149.3">NP_000149.3</ext-link>
                </td>
              </tr>
              <tr>
                <td headers="hd_h_gsd4.T.selected_gbe1_pathogenic_variants_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.1544G&#x0003e;A</td>
                <td headers="hd_h_gsd4.T.selected_gbe1_pathogenic_variants_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Arg515His</td>
                <td headers="hd_h_gsd4.T.selected_gbe1_pathogenic_variants_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">APBD</td>
              </tr>
              <tr>
                <td headers="hd_h_gsd4.T.selected_gbe1_pathogenic_variants_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.1571G&#x0003e;A</td>
                <td headers="hd_h_gsd4.T.selected_gbe1_pathogenic_variants_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Arg524Gln</td>
                <td headers="hd_h_gsd4.T.selected_gbe1_pathogenic_variants_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Classic hepatic;<break/>Non-progressive hepatic, APBD</td>
              </tr>
            </tbody>
          </table>
          <table-wrap-foot>
            <fn>
              <p>Note on variant classification: Variants listed in the table have been provided by the authors. <italic toggle="yes">GeneReviews</italic> staff have not independently verified the classification of variants.</p>
            </fn>
            <fn>
              <p>Note on nomenclature: <italic toggle="yes">GeneReviews</italic> follows the standard naming conventions of the Human Genome Variation Society (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://varnomen.hgvs.org/">varnomen.hgvs.org</ext-link>). See <related-object link-type="booklink" source-id="gene" document-id="app3" document-type="appendix">Quick Reference</related-object> for an explanation of nomenclature.</p>
            </fn>
          </table-wrap-foot>
        </table-wrap>
        <p>See <inline-supplementary-material xmlns:xlink="http://www.w3.org/1999/xlink" xlink:title="media" xlink:href="gsd4-Table3.pdf" content-type="local-data">Table 3</inline-supplementary-material> (pdf) for a complete list of <italic toggle="yes">GBE1</italic> pathogenic variants identified to date.</p>
        <p><bold>Normal gene product.</bold> Glycogen branching enzyme (GBE), a 702-amino acid protein, catalyzes the transfer of alpha-1,4-linked glucosyl units from the outer end of a glycogen chain to an alpha-1,6 position on the same or a neighboring glycogen chain. Branching of the chains is essential to increase the solubility of the glycogen molecule and, consequently, reduce the osmotic pressure within cells [<xref ref-type="bibr" rid="gsd4.REF.thon.1993.7509">Thon et al 1993</xref>]. The GBE protein contains two highly conserved domains at the N- and C-terminals with sequences similar to isoamylase (glycoside hydrolase) and alpha-amylase, respectively. These two domains flank the alpha-amylase catalytic domain that encompasses the central portion of the enzyme [<xref ref-type="bibr" rid="gsd4.REF.moses.2002.177">Moses &#x00026; Parvari 2002</xref>].</p>
        <p><bold>Abnormal gene product.</bold> The underlying molecular defects in <italic toggle="yes">GBE1</italic> lead to the production of little or no functional GBE, resulting in abnormally formed glycogen (with fewer branch points and longer unbranched outer chains) with an amylopectin-like structure that accumulates in various tissues, most commonly the liver, heart, muscle, brain, spinal cord, peripheral nerve, and skin [<xref ref-type="bibr" rid="gsd4.REF.thon.1993.7509">Thon et al 1993</xref>, <xref ref-type="bibr" rid="gsd4.REF.chen.2001">Chen 2001</xref>, <xref ref-type="bibr" rid="gsd4.REF.moses.2002.177">Moses &#x00026; Parvari 2002</xref>]. It has been postulated that alteration in the glycogen branching structure that makes it less soluble may result in a foreign body reaction that leads to the tissue injury and dysfunction observed in GSD IV [<xref ref-type="bibr" rid="gsd4.REF.howell.1991.55">Howell 1991</xref>]; however, the specific pathologic mechanisms remain unknown.</p>
      </sec>
      <sec id="gsd4.References">
        <title>References</title>
        <sec id="gsd4.Literature_Cited">
          <title>Literature Cited</title>
          <ref-list id="gsd4.Literature_Cited.reflist0">
            <ref id="gsd4.REF.akman.2006.951">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Akman</surname>
                    <given-names>HO</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Karadimas</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gyftodimou</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Grigoriadou</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kokotas</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Konstantinidou</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Anninos</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Patsouris</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Thaker</surname>
                    <given-names>HM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kaplan</surname>
                    <given-names>JB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Besharat</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hatzikonstantinou</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fotopoulos</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dimauro</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Petersen</surname>
                    <given-names>MB</given-names>
                  </name>
                </person-group>
                <article-title>Prenatal diagnosis of glycogen storage disease type IV.</article-title>
                <source>Prenat Diagn.</source>
                <year>2006</year>
                <volume>26</volume>
                <fpage>951</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">16874838</pub-id>
              </element-citation>
            </ref>
            <ref id="gsd4.REF.assereto.2007.445">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Assereto</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Diggelen</surname>
                    <given-names>OP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Diogo</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Morava</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cassandrini</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Carreira</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Boode</surname>
                    <given-names>WP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dilling</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Garcia</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Henriques</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rebelo</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>ter Laak</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Minetti</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bruno</surname>
                    <given-names>C</given-names>
                  </name>
                </person-group>
                <article-title>Null mutations and lethal congenital form of glycogen storage disease type IV.</article-title>
                <source>Biochem Biophys Res Commun.</source>
                <year>2007</year>
                <volume>361</volume>
                <fpage>445</fpage>
                <lpage>50</lpage>
                <pub-id pub-id-type="pmid">17662246</pub-id>
              </element-citation>
            </ref>
            <ref id="gsd4.REF.bao.1996.941">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Bao</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kishnani</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wu</surname>
                    <given-names>JY</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chen</surname>
                    <given-names>YT</given-names>
                  </name>
                </person-group>
                <article-title>Hepatic and neuromuscular forms of glycogen storage disease type IV caused by mutations in the same glycogen-branching enzyme gene.</article-title>
                <source>J Clin Invest.</source>
                <year>1996</year>
                <volume>97</volume>
                <fpage>941</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">8613547</pub-id>
              </element-citation>
            </ref>
            <ref id="gsd4.REF.brown.1983.636">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Brown</surname>
                    <given-names>DH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brown</surname>
                    <given-names>BI</given-names>
                  </name>
                </person-group>
                <article-title>Studies of the residual glycogen branching enzyme activity present in human skin fibroblasts from patients with type IV glycogen storage disease.</article-title>
                <source>Biochem Biophys Res Commun.</source>
                <year>1983</year>
                <volume>111</volume>
                <fpage>636</fpage>
                <lpage>43</lpage>
                <pub-id pub-id-type="pmid">6220706</pub-id>
              </element-citation>
            </ref>
            <ref id="gsd4.REF.bruno.1999.403">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Bruno</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>DiRocco</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lamba</surname>
                    <given-names>LD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bado</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Marino</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tsujino</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shanske</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stella</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Minetti</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Diggelen</surname>
                    <given-names>OP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>DiMauro</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <article-title>A novel missense mutation in the glycogen branching enzyme gene in a child with myopathy and hepatopathy.</article-title>
                <source>Neuromuscul Disord.</source>
                <year>1999</year>
                <volume>9</volume>
                <fpage>403</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">10545044</pub-id>
              </element-citation>
            </ref>
            <ref id="gsd4.REF.bruno.2004.1053">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Bruno</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Diggelen</surname>
                    <given-names>OP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cassandrini</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gimpelev</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Giuffr&#x000e8;</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Donati</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Introvini</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Alegria</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Assereto</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Morandi</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mora</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tonoli</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mascelli</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Traverso</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pasquini</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bado</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vilarinho</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Noort</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mosca</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>DiMauro</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zara</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Minetti</surname>
                    <given-names>C</given-names>
                  </name>
                </person-group>
                <article-title>Clinical and genetic heterogeneity of branching enzyme deficiency (glycogenosis type IV).</article-title>
                <source>Neurology.</source>
                <year>2004</year>
                <volume>63</volume>
                <fpage>1053</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">15452297</pub-id>
              </element-citation>
            </ref>
            <ref id="gsd4.REF.burrow.2006.878">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Burrow</surname>
                    <given-names>TA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hopkin</surname>
                    <given-names>RJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bove</surname>
                    <given-names>KE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Miles</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wong</surname>
                    <given-names>BL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Choudhary</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bali</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Li</surname>
                    <given-names>SC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chen</surname>
                    <given-names>YT</given-names>
                  </name>
                </person-group>
                <article-title>Non-lethal congenital hypotonia due to glycogen storage disease type IV.</article-title>
                <source>Am J Med Genet A.</source>
                <year>2006</year>
                <volume>140</volume>
                <fpage>878</fpage>
                <lpage>82</lpage>
                <pub-id pub-id-type="pmid">16528737</pub-id>
              </element-citation>
            </ref>
            <ref id="gsd4.REF.chen.2001">
              <mixed-citation publication-type="book">Chen Y. Glycogen storage disease. In: Scriver CR, Beaudet AS, Sly WS, Valle D, Childs B, Kinzler KW, Vogelstein B, eds. <italic toggle="yes">The Metabolic and Molecular Basis of Inherited Disease</italic>. 8 ed. New York, NY: McGraw-Hill; 2001:1521-51.</mixed-citation>
            </ref>
            <ref id="gsd4.REF.davis.2008.137">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Davis</surname>
                    <given-names>MK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Weinstein</surname>
                    <given-names>DA</given-names>
                  </name>
                </person-group>
                <article-title>Liver transplantation in children with glycogen storage disease: controversies and evaluation of the risk/benefit of this procedure.</article-title>
                <source>Pediatr Transplant.</source>
                <year>2008</year>
                <volume>12</volume>
                <fpage>137</fpage>
                <lpage>45</lpage>
                <pub-id pub-id-type="pmid">18307661</pub-id>
              </element-citation>
            </ref>
            <ref id="gsd4.REF.ewert.1999.850">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ewert</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gulijew</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wensel</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dandel</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hummel</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vogel</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Meyer</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hetzer</surname>
                    <given-names>R.</given-names>
                  </name>
                </person-group>
                <article-title>Glycogenosis type IV as a seldom cause of cardiomyopathy - report about a successful heart transplantation</article-title>
                <source>Z Kardiol.</source>
                <year>1999</year>
                <volume>88</volume>
                <fpage>850</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">10552189</pub-id>
              </element-citation>
            </ref>
            <ref id="gsd4.REF.howell.1991.55">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Howell</surname>
                    <given-names>RR</given-names>
                  </name>
                </person-group>
                <article-title>Continuing lessons from glycogen storage diseases.</article-title>
                <source>N Engl J Med.</source>
                <year>1991</year>
                <volume>324</volume>
                <fpage>55</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">1984166</pub-id>
              </element-citation>
            </ref>
            <ref id="gsd4.REF.janecke.2004.705">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Janecke</surname>
                    <given-names>AR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dertinger</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ketelsen</surname>
                    <given-names>UP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bereuter</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Simma</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>M&#x000fc;ller</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vogel</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Offner</surname>
                    <given-names>FA</given-names>
                  </name>
                </person-group>
                <article-title>Neonatal type IV glycogen storage disease associated with "null" mutations in glycogen branching enzyme 1.</article-title>
                <source>J Pediatr.</source>
                <year>2004</year>
                <volume>145</volume>
                <fpage>705</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">15520786</pub-id>
              </element-citation>
            </ref>
            <ref id="gsd4.REF.klein.2004.323">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Klein</surname>
                    <given-names>CJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boes</surname>
                    <given-names>CJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chapin</surname>
                    <given-names>JE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lynch</surname>
                    <given-names>CD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Campeau</surname>
                    <given-names>NG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dyck</surname>
                    <given-names>PJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dyck</surname>
                    <given-names>PJ</given-names>
                  </name>
                </person-group>
                <article-title>Adult polyglucosan body disease: case description of an expanding genetic and clinical syndrome.</article-title>
                <source>Muscle Nerve.</source>
                <year>2004</year>
                <volume>29</volume>
                <fpage>323</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">14755501</pub-id>
              </element-citation>
            </ref>
            <ref id="gsd4.REF.lamperti.2009.s161">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Lamperti</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Salani</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lucchiari</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bordoni</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ripolone</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fagiolari</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fruguglietti</surname>
                    <given-names>ME</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Crugnola</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Colombo</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cappellini</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Prelle</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bresolin</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Comi</surname>
                    <given-names>GP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moggio</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <article-title>Neuropathological study of skeletal muscle, heart, liver, and brain in a neonatal form of glycogen storage disease type IV associated with a new mutation in GBE1 gene.</article-title>
                <source>J Inherit Metab Dis.</source>
                <year>2009</year>
                <volume>32</volume>
                <fpage>S161</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">19357989</pub-id>
              </element-citation>
            </ref>
            <ref id="gsd4.REF.lhermin_coulomb.2005.118">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>L'Hermin&#x000e9;-Coulomb</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Beuzen</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bouvier</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rolland</surname>
                    <given-names>MO</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Froissart</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Menez</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Audibert</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Labrune</surname>
                    <given-names>P</given-names>
                  </name>
                </person-group>
                <article-title>Fetal type IV glycogen storage disease: clinical, enzymatic, and genetic data of a pure muscular form with variable and early antenatal manifestations in the same family.</article-title>
                <source>Am J Med Genet A.</source>
                <year>2005</year>
                <volume>139A</volume>
                <fpage>118</fpage>
                <lpage>22</lpage>
                <pub-id pub-id-type="pmid">16278887</pub-id>
              </element-citation>
            </ref>
            <ref id="gsd4.REF.li.2010.s83">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Li</surname>
                    <given-names>SC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chen</surname>
                    <given-names>CM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goldstein</surname>
                    <given-names>JL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wu</surname>
                    <given-names>JY</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lemyre</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Burrow</surname>
                    <given-names>TA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kang</surname>
                    <given-names>PB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chen</surname>
                    <given-names>YT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bali</surname>
                    <given-names>DS</given-names>
                  </name>
                </person-group>
                <article-title>Glycogen storage disease type IV: novel mutations and molecular characterization of a heterogeneous disorder.</article-title>
                <source>J Inherit Metab Dis.</source>
                <year>2010</year>
                <volume>33</volume>
                <fpage>S83</fpage>
                <lpage>90</lpage>
                <pub-id pub-id-type="pmid">20058079</pub-id>
              </element-citation>
            </ref>
            <ref id="gsd4.REF.li.2012.204">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Li</surname>
                    <given-names>SC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hwu</surname>
                    <given-names>WL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lin</surname>
                    <given-names>JL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bali</surname>
                    <given-names>DS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yang</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chu</surname>
                    <given-names>SM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chien</surname>
                    <given-names>YH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chou</surname>
                    <given-names>HC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chen</surname>
                    <given-names>CY</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hsieh</surname>
                    <given-names>WS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tsao</surname>
                    <given-names>PN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chen</surname>
                    <given-names>YT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lee</surname>
                    <given-names>NC</given-names>
                  </name>
                </person-group>
                <article-title>Association of the congenital neuromuscular form of glycogen storage disease type IV with a large deletion and recurrent frameshift mutation.</article-title>
                <source>J Child Neurol.</source>
                <year>2012</year>
                <volume>27</volume>
                <fpage>204</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">21917543</pub-id>
              </element-citation>
            </ref>
            <ref id="gsd4.REF.lossos.1998.867">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Lossos</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Meiner</surname>
                    <given-names>Z</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barash</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Soffer</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schlesinger</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Abramsky</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Argov</surname>
                    <given-names>Z</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shpitzen</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Meiner</surname>
                    <given-names>V</given-names>
                  </name>
                </person-group>
                <article-title>Adult polyglucosan body disease in Ashkenazi Jewish patients carrying the Tyr329Ser mutation in the glycogen-branching enzyme gene.</article-title>
                <source>Ann Neurol.</source>
                <year>1998</year>
                <volume>44</volume>
                <fpage>867</fpage>
                <lpage>72</lpage>
                <pub-id pub-id-type="pmid">9851430</pub-id>
              </element-citation>
            </ref>
            <ref id="gsd4.REF.magoulas.2012.943">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Magoulas</surname>
                    <given-names>PL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>El-Hattab</surname>
                    <given-names>AW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Roy</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bali</surname>
                    <given-names>DS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Finegold</surname>
                    <given-names>MJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Craigen</surname>
                    <given-names>WJ</given-names>
                  </name>
                </person-group>
                <article-title>Diffuse reticuloendothelial system involvement in type IV glycogen storage disease with a novel GBE1 mutation: a case report and review.</article-title>
                <source>Hum Pathol.</source>
                <year>2012</year>
                <volume>43</volume>
                <fpage>943</fpage>
                <lpage>51</lpage>
                <pub-id pub-id-type="pmid">22305237</pub-id>
              </element-citation>
            </ref>
            <ref id="gsd4.REF.mcconkierosell.1996.51">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>McConkie-Rosell</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wilson</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Piccoli</surname>
                    <given-names>DA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boyle</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>DeClue</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kishnani</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shen</surname>
                    <given-names>JJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boney</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brown</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chen</surname>
                    <given-names>YT</given-names>
                  </name>
                </person-group>
                <article-title>Clinical and laboratory findings in four patients with the non-progressive hepatic form of type IV glycogen storage disease.</article-title>
                <source>J Inherit Metab Dis.</source>
                <year>1996</year>
                <volume>19</volume>
                <fpage>51</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">8830177</pub-id>
              </element-citation>
            </ref>
            <ref id="gsd4.REF.moses.2002.177">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Moses</surname>
                    <given-names>SW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Parvari</surname>
                    <given-names>R</given-names>
                  </name>
                </person-group>
                <article-title>The variable presentations of glycogen storage disease type IV: a review of clinical, enzymatic and molecular studies.</article-title>
                <source>Curr Mol Med.</source>
                <year>2002</year>
                <volume>2</volume>
                <fpage>177</fpage>
                <lpage>88</lpage>
                <pub-id pub-id-type="pmid">11949934</pub-id>
              </element-citation>
            </ref>
            <ref id="gsd4.REF.nambu.2003.392">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Nambu</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kawabe</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fukuda</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Okuno</surname>
                    <given-names>TB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ohta</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nonaka</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sugie</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nishino</surname>
                    <given-names>I</given-names>
                  </name>
                </person-group>
                <article-title>A neonatal form of glycogen storage disease type IV.</article-title>
                <source>Neurology.</source>
                <year>2003</year>
                <volume>61</volume>
                <fpage>392</fpage>
                <lpage>4</lpage>
                <pub-id pub-id-type="pmid">12913206</pub-id>
              </element-citation>
            </ref>
            <ref id="gsd4.REF.nolte.2008.491">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Nolte</surname>
                    <given-names>KW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Janecke</surname>
                    <given-names>AR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vorgerd</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Weis</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schr&#x000f6;der</surname>
                    <given-names>JM</given-names>
                  </name>
                </person-group>
                <article-title>Congenital type IV glycogenosis: the spectrum of pleomorphic polyglucosan bodies in muscle, nerve, and spinal cord with two novel mutations in the GBE1 gene.</article-title>
                <source>Acta Neuropathol.</source>
                <year>2008</year>
                <volume>116</volume>
                <fpage>491</fpage>
                <lpage>506</lpage>
                <pub-id pub-id-type="pmid">18661138</pub-id>
              </element-citation>
            </ref>
            <ref id="gsd4.REF.raju.2008.349">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Raju</surname>
                    <given-names>GP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Li</surname>
                    <given-names>HC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bali</surname>
                    <given-names>DS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chen</surname>
                    <given-names>YT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Urion</surname>
                    <given-names>DK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lidov</surname>
                    <given-names>HG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kang</surname>
                    <given-names>PB</given-names>
                  </name>
                </person-group>
                <article-title>A case of congenital glycogen storage disease type IV with a novel GBE1 mutation.</article-title>
                <source>J Child Neurol.</source>
                <year>2008</year>
                <volume>23</volume>
                <fpage>349</fpage>
                <lpage>52</lpage>
                <pub-id pub-id-type="pmid">18230843</pub-id>
              </element-citation>
            </ref>
            <ref id="gsd4.REF.reusche.1992.36">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Reusche</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Aksu</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goebel</surname>
                    <given-names>HH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shin</surname>
                    <given-names>YS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yokota</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Reichmann</surname>
                    <given-names>H</given-names>
                  </name>
                </person-group>
                <article-title>A mild juvenile variant of type IV glycogenosis.</article-title>
                <source>Brain Dev.</source>
                <year>1992</year>
                <volume>14</volume>
                <fpage>36</fpage>
                <lpage>43</lpage>
                <pub-id pub-id-type="pmid">1375445</pub-id>
              </element-citation>
            </ref>
            <ref id="gsd4.REF.rosenthal.1995.373">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Rosenthal</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Podesta</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Grier</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Said</surname>
                    <given-names>JW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sher</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cocjin</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Watanabe</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vasiliauskas</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van de Velde</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Makowka</surname>
                    <given-names>L</given-names>
                  </name>
                </person-group>
                <article-title>Failure of liver transplantation to diminish cardiac deposits of amylopectin and leukocyte inclusions in type IV glycogen storage disease.</article-title>
                <source>Liver Transpl Surg.</source>
                <year>1995</year>
                <volume>1</volume>
                <fpage>373</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">9346615</pub-id>
              </element-citation>
            </ref>
            <ref id="gsd4.REF.schr_der.1993.419">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Schr&#x000f6;der</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>May</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shin</surname>
                    <given-names>YS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sigmund</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nase-H&#x000fc;ppmeier</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <article-title>Juvenile hereditary polyglucosan body disease with complete branching enzyme deficiency (type IV glycogenosis).</article-title>
                <source>Acta Neuropathol.</source>
                <year>1993</year>
                <volume>85</volume>
                <fpage>419</fpage>
                <lpage>30</lpage>
                <pub-id pub-id-type="pmid">7683169</pub-id>
              </element-citation>
            </ref>
            <ref id="gsd4.REF.shin.2006.115">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Shin</surname>
                    <given-names>YS</given-names>
                  </name>
                </person-group>
                <article-title>Glycogen storage disease: clinical, biochemical, and molecular heterogeneity.</article-title>
                <source>Semin Pediatr Neurol.</source>
                <year>2006</year>
                <volume>13</volume>
                <fpage>115</fpage>
                <lpage>20</lpage>
                <pub-id pub-id-type="pmid">17027861</pub-id>
              </element-citation>
            </ref>
            <ref id="gsd4.REF.sokal.1992.200">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Sokal</surname>
                    <given-names>EM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Van Hoof</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Alberti</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Ville de Goyet</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Barsy</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Otte</surname>
                    <given-names>JB</given-names>
                  </name>
                </person-group>
                <article-title>Progressive cardiac failure following orthotopic liver transplantation for type IV glycogenosis.</article-title>
                <source>Eur J Pediatr.</source>
                <year>1992</year>
                <volume>151</volume>
                <fpage>200</fpage>
                <lpage>3</lpage>
                <pub-id pub-id-type="pmid">1601012</pub-id>
              </element-citation>
            </ref>
            <ref id="gsd4.REF.tay.2004.253">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Tay</surname>
                    <given-names>SK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Akman</surname>
                    <given-names>HO</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chung</surname>
                    <given-names>WK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pike</surname>
                    <given-names>MG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Muntoni</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hays</surname>
                    <given-names>AP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shanske</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Valberg</surname>
                    <given-names>SJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mickelson</surname>
                    <given-names>JR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tanji</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>DiMauro</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <article-title>Fatal infantile neuromuscular presentation of glycogen storage disease type IV.</article-title>
                <source>Neuromuscul Disord.</source>
                <year>2004</year>
                <volume>14</volume>
                <fpage>253</fpage>
                <lpage>60</lpage>
                <pub-id pub-id-type="pmid">15019703</pub-id>
              </element-citation>
            </ref>
            <ref id="gsd4.REF.thon.1993.7509">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Thon</surname>
                    <given-names>VJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Khalil</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cannon</surname>
                    <given-names>JF</given-names>
                  </name>
                </person-group>
                <article-title>Isolation of human glycogen branching enzyme cDNAs by screening complementation in yeast.</article-title>
                <source>J Biol Chem.</source>
                <year>1993</year>
                <volume>268</volume>
                <fpage>7509</fpage>
                <lpage>13</lpage>
                <pub-id pub-id-type="pmid">8463281</pub-id>
              </element-citation>
            </ref>
            <ref id="gsd4.REF.ziemssen.2000.536">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ziemssen</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sindern</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schr&#x000f6;der</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shin</surname>
                    <given-names>YS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zange</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kilimann</surname>
                    <given-names>MW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Malin</surname>
                    <given-names>JP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vorgerd</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <article-title>Novel missense mutations in the glycogen-branching enzyme gene in adult polyglucosan body disease.</article-title>
                <source>Ann Neurol.</source>
                <year>2000</year>
                <volume>47</volume>
                <fpage>536</fpage>
                <lpage>40</lpage>
                <pub-id pub-id-type="pmid">10762170</pub-id>
              </element-citation>
            </ref>
          </ref-list>
        </sec>
        <sec id="gsd4.Suggested_Reading">
          <title>Suggested Reading</title>
          <ref-list id="gsd4.Suggested_Reading.reflist0">
            <ref id="gsd4.REF.massa.2008.530">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Massa</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bruno</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Martorana</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Stefano</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Diggelen</surname>
                    <given-names>OP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Federico</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <article-title>Adult polyglucosan body disease: proton magnetic resonance spectroscopy of the brain and novel mutation in the GBE1 gene.</article-title>
                <source>Muscle Nerve.</source>
                <year>2008</year>
                <volume>37</volume>
                <fpage>530</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">17994551</pub-id>
              </element-citation>
            </ref>
          </ref-list>
        </sec>
      </sec>
      <sec id="gsd4.Chapter_Notes">
        <title>Chapter Notes</title>
        <sec id="gsd4.Revision_History">
          <title>Revision History</title>
          <list list-type="bullet">
            <list-item>
              <p>3 January 2013 (me) Review posted live</p>
            </list-item>
            <list-item>
              <p>17 September 2012 (aeh) Original submission</p>
            </list-item>
          </list>
        </sec>
      </sec>
    </body>
  </book-part>
</book-part-wrapper>
